N. Vanukuru, G. R. Mudunuri, Prathyusha Bhimasani, Niharika Malipatel, Mahesh Thorat, H. Tare
{"title":"Coriandrum sativum对啮齿类动物应激和认知障碍的临床前评估和计算机对接","authors":"N. Vanukuru, G. R. Mudunuri, Prathyusha Bhimasani, Niharika Malipatel, Mahesh Thorat, H. Tare","doi":"10.25258/ijpqa.14.1.08","DOIUrl":null,"url":null,"abstract":"Ethanolic extract aerial portions of Coriandrum sativum (EECS) were tested for their anxiolytic eff ects on the cold-resistant stress test after seven days of treatment and their cognitive boosting eff ects after eight days of therapy (EECS). Total phenolic content and fl avonoid compound levels were calculated. C. sativum showed anti-stress effi cacy in a cold-resistant stress animal at 200 and 400 mg/kg doses. The plasma glucose, triglyceride, cholesterol levels, as well as the weight of the adrenal glands are all aff ected by the stimulation of the HPA in stressful situations. Pre-treatment with EECS and Geriforte, which contain secondary metabolites such as fl avonoids, glycosides, triterpenoids, and phenolic compounds, signifi cantly reduced stress-induced changes in these biochemical levels in cold stress animals. Screening for acetylcholinesterase inhibition activity in-vitro using Ellman’s approach increased AChE inhibition dose-dependently in the brains of mice. The data proved that the extract’s potential to reduce pain in-vitro is what led to the observed cognitive benefi ts in-vivo. Animals given EECS at 200 and 400 mg/kg had their infl exion ratio improved as a result of the memory defi cit being reversed. The scopolamine-induced amnesia group of mice showed degeneration of vacuolated cells, pyramidal cells, pyknosis, loss of architecture and the creation of lesions in the hippocampus; however, these characteristics were restored by EECS and standard therapy. Eff ective docking scores in mcule software were observed for interactions with receptors PDB: 4K5Y (CRF-1) for adaptogenic and PDB: 1E66 (AChE) for cognition, according to in-silico research. The ethanolic extract of C. sativum has been shown to have positive and scientifi cally-supported eff ects on human health when used as a nutraceutical, with the in-vitro acetylcholinesterase Inhibition assay, anti-stress, and cognitive enhancement activities, and in-silico studies all corroborated by this study.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-clinical Evaluation and In-silico Docking of Coriandrum sativum on Stress and Cognitive Defi cits in Rodents\",\"authors\":\"N. Vanukuru, G. R. Mudunuri, Prathyusha Bhimasani, Niharika Malipatel, Mahesh Thorat, H. Tare\",\"doi\":\"10.25258/ijpqa.14.1.08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ethanolic extract aerial portions of Coriandrum sativum (EECS) were tested for their anxiolytic eff ects on the cold-resistant stress test after seven days of treatment and their cognitive boosting eff ects after eight days of therapy (EECS). Total phenolic content and fl avonoid compound levels were calculated. C. sativum showed anti-stress effi cacy in a cold-resistant stress animal at 200 and 400 mg/kg doses. The plasma glucose, triglyceride, cholesterol levels, as well as the weight of the adrenal glands are all aff ected by the stimulation of the HPA in stressful situations. Pre-treatment with EECS and Geriforte, which contain secondary metabolites such as fl avonoids, glycosides, triterpenoids, and phenolic compounds, signifi cantly reduced stress-induced changes in these biochemical levels in cold stress animals. Screening for acetylcholinesterase inhibition activity in-vitro using Ellman’s approach increased AChE inhibition dose-dependently in the brains of mice. The data proved that the extract’s potential to reduce pain in-vitro is what led to the observed cognitive benefi ts in-vivo. Animals given EECS at 200 and 400 mg/kg had their infl exion ratio improved as a result of the memory defi cit being reversed. The scopolamine-induced amnesia group of mice showed degeneration of vacuolated cells, pyramidal cells, pyknosis, loss of architecture and the creation of lesions in the hippocampus; however, these characteristics were restored by EECS and standard therapy. Eff ective docking scores in mcule software were observed for interactions with receptors PDB: 4K5Y (CRF-1) for adaptogenic and PDB: 1E66 (AChE) for cognition, according to in-silico research. The ethanolic extract of C. sativum has been shown to have positive and scientifi cally-supported eff ects on human health when used as a nutraceutical, with the in-vitro acetylcholinesterase Inhibition assay, anti-stress, and cognitive enhancement activities, and in-silico studies all corroborated by this study.\",\"PeriodicalId\":14260,\"journal\":{\"name\":\"International Journal of Pharmaceutical Quality Assurance\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutical Quality Assurance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25258/ijpqa.14.1.08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical Quality Assurance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25258/ijpqa.14.1.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Pre-clinical Evaluation and In-silico Docking of Coriandrum sativum on Stress and Cognitive Defi cits in Rodents
Ethanolic extract aerial portions of Coriandrum sativum (EECS) were tested for their anxiolytic eff ects on the cold-resistant stress test after seven days of treatment and their cognitive boosting eff ects after eight days of therapy (EECS). Total phenolic content and fl avonoid compound levels were calculated. C. sativum showed anti-stress effi cacy in a cold-resistant stress animal at 200 and 400 mg/kg doses. The plasma glucose, triglyceride, cholesterol levels, as well as the weight of the adrenal glands are all aff ected by the stimulation of the HPA in stressful situations. Pre-treatment with EECS and Geriforte, which contain secondary metabolites such as fl avonoids, glycosides, triterpenoids, and phenolic compounds, signifi cantly reduced stress-induced changes in these biochemical levels in cold stress animals. Screening for acetylcholinesterase inhibition activity in-vitro using Ellman’s approach increased AChE inhibition dose-dependently in the brains of mice. The data proved that the extract’s potential to reduce pain in-vitro is what led to the observed cognitive benefi ts in-vivo. Animals given EECS at 200 and 400 mg/kg had their infl exion ratio improved as a result of the memory defi cit being reversed. The scopolamine-induced amnesia group of mice showed degeneration of vacuolated cells, pyramidal cells, pyknosis, loss of architecture and the creation of lesions in the hippocampus; however, these characteristics were restored by EECS and standard therapy. Eff ective docking scores in mcule software were observed for interactions with receptors PDB: 4K5Y (CRF-1) for adaptogenic and PDB: 1E66 (AChE) for cognition, according to in-silico research. The ethanolic extract of C. sativum has been shown to have positive and scientifi cally-supported eff ects on human health when used as a nutraceutical, with the in-vitro acetylcholinesterase Inhibition assay, anti-stress, and cognitive enhancement activities, and in-silico studies all corroborated by this study.
期刊介绍:
INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE is a quarterly international journal publishing the finest peer-reviewed research in the field of Pharmaceutical Quality Assurance and Pharmaceutical Analysis on the basis of its originality, importance, disciplinary interest, timeliness, accessibility, elegance, and surprising conclusions. IJPQA also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.